TY - JOUR
T1 - Acceptability and Feasibility of Saliva-delivered PCR Coronavirus 2019 Tests for Young Children
AU - Lee, Rebecca E.
AU - Todd, Michael
AU - Oh, Hyunsung
AU - Han, Seung Yong
AU - Santana, Michelle
AU - Aguilar-Troncoso, Jaquelyn
AU - Bruening, Meg
AU - Kramer, Joanna L.
AU - Leon, Tomas
AU - Murugan, Vel
AU - Valdez, Hector
AU - Villegas-Gold, Michelle
N1 - Publisher Copyright:
Copyright © 2023 by the American Academy of Pediatrics.
PY - 2023/7/1
Y1 - 2023/7/1
N2 - OBJECTIVES: Access to readily available, reliable, and easy-to-use coronavirus disease 2019 (COVID-19) tests remains critical, despite great vaccination progress. Universal back-to-school testing offered at early care and education ([ECE]; ie, preschool) sites to screen for positive cases may help preschoolers safely return to, and stay in, ECE. We examined the acceptability and feasibility of using a quantitative polymerase chain reaction COVID-19 saliva test for young children (n 5 227, 54.0% girls: mean age 5 52.3 ± 8.1 months) and their caregivers (n 5 70 teachers: mean 5 36.6 ± 14.7 years; n 5 227 parents: mean 5 35.5 ± 9.1 years) to mitigate the spread of COVID-19 and reduce days of school and work missed for households with children who test positive. METHODS: Participants were recruited at ECE sites serving low-income communities as part of the Rapid Acceleration of Diagnostic Testing–Underserved Populations Back to Early Care and Education Safely with Sustainability via Active Garden Education project (NCT05178290). RESULTS: Surveys in English or Spanish administered at testing events to children and caregivers at ECE sites showed child and adult acceptability and feasibility ratings were generally high. More favorable child and parent ratings were positively associated with child age and whether the child was able to produce a saliva sample. Language preference was not associated with any outcomes. CONCLUSIONS: Saliva sampling for COVID-19 at ECE sites is an acceptable strategy as an additional layer of protection for 4- and 5-year-olds; however, alternate testing strategies may be needed for younger children.
AB - OBJECTIVES: Access to readily available, reliable, and easy-to-use coronavirus disease 2019 (COVID-19) tests remains critical, despite great vaccination progress. Universal back-to-school testing offered at early care and education ([ECE]; ie, preschool) sites to screen for positive cases may help preschoolers safely return to, and stay in, ECE. We examined the acceptability and feasibility of using a quantitative polymerase chain reaction COVID-19 saliva test for young children (n 5 227, 54.0% girls: mean age 5 52.3 ± 8.1 months) and their caregivers (n 5 70 teachers: mean 5 36.6 ± 14.7 years; n 5 227 parents: mean 5 35.5 ± 9.1 years) to mitigate the spread of COVID-19 and reduce days of school and work missed for households with children who test positive. METHODS: Participants were recruited at ECE sites serving low-income communities as part of the Rapid Acceleration of Diagnostic Testing–Underserved Populations Back to Early Care and Education Safely with Sustainability via Active Garden Education project (NCT05178290). RESULTS: Surveys in English or Spanish administered at testing events to children and caregivers at ECE sites showed child and adult acceptability and feasibility ratings were generally high. More favorable child and parent ratings were positively associated with child age and whether the child was able to produce a saliva sample. Language preference was not associated with any outcomes. CONCLUSIONS: Saliva sampling for COVID-19 at ECE sites is an acceptable strategy as an additional layer of protection for 4- and 5-year-olds; however, alternate testing strategies may be needed for younger children.
UR - http://www.scopus.com/inward/record.url?scp=85163582398&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85163582398&partnerID=8YFLogxK
U2 - 10.1542/peds.2022-060352D
DO - 10.1542/peds.2022-060352D
M3 - Article
C2 - 37394507
AN - SCOPUS:85163582398
SN - 0031-4005
VL - 152
SP - S1-S11
JO - Pediatrics
JF - Pediatrics
ER -